News
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast ...
Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity - ...
The study suggests that aspartame consumption could foster conditions in the gut conducive to tumour growth. Notably, ...
A new Chinese study has uncovered a worrying connection between aspartame, a common sugar substitute, and glioblastoma. Which ...
A New Zealand bariatric surgeon cautions that Wegovy, a new weight-loss drug, isn't a magic bullet for obesity. While it can trigger initial weight loss, long-term success hinges on lifestyle changes ...
Proven, science-based treatments such as Botox,® Dysport,® Restylane® and Juvederm® injectables are available, as are treatments such Hydrafacial MD Elite, a gentle yet revitalizing treatment that ...
1h
The Sunday Guardian Live on MSNTo Ozempic or to Mounjaro? The weight loss drug primerIndia's top endocrinologist, Dr Ambrish Mithal has come out with a very well timed and a much needed explainer on the new crop of weight loss drugs that have flooded the market. Entitled, "The Weight ...
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results